3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
5
Thoracic
1
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
11
Carcinoma, Ovarian Epithelial
2
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Lethal Congenital Contracture Syndrome 2
1
Hodgkin Disease
1
Graft vs Host Disease
1
Esophageal Squamous Cell Carcinoma
1
Interventions
Psychiatric Rehabilitation
8
Magnetic Resonance Spectroscopy
7
Gemcitabine
7
Capecitabine
7
pembrolizumab
6
Early Intervention, Educational
6
Drug Therapy
6
Cyclophosphamide
6
Methods
5
Therapeutics
4
Specimen Handling
4
Mental Status and Dementia Tests
4
Docetaxel
4
veliparib
3
selpercatinib
3
sargramostim
3
palbociclib
3
cediranib
3
Trastuzumab
3
Surveys and Questionnaires
3
Standard of Care
3
Radiotherapy
3
Paclitaxel
3
Oxaliplatin
3
Irinotecan
3
Fluorodeoxyglucose F18
3
Counseling
3
Cisplatin
3
Carboplatin
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
In Situ Hybridization, Fluorescence
×
Breast
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled